Clinical Trials

38 enrolled

Rectal Neoplasms

NCT04652440 2023-04-19

Ablation Combined With PD-1 in HCC: Phase II Study

Phase 1/2 Unknown

30 enrolled

Carcinoma, Hepatocellular

NCT04030260 2023-03-23

Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer

28 enrolled

Colorectal Cancer Metastatic

NCT05684211 2023-02-01

A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer

84 enrolled

Colorectal Neoplasms

NCT05468138 2022-08-26

PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

141 enrolled

Stomach Neoplasms

NCT03668431 2022-06-27

Dabrafenib + Trametinib + PDR001 In Colorectal Cancer

25 enrolled

Colorectal Neoplasms

NCT03374293 2021-02-10

Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer

21 enrolled

Pancreatic Neoplasms

NCT04711434 2021-01-20

PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients

Phase 3 Unknown

260 enrolled

Colorectal Neoplasms, Hereditary Nonpolyposis

NCT03989310 2020-12-23

An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Phase 1/2 Unknown

50 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT04663763 2020-12-11

Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer

40 enrolled

Locally Advanced Rectal Cancer

NCT04411524 2020-06-02

The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer

50 enrolled

Locally Advanced Rectal Cancer

NCT04411537 2020-06-02

The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer

50 enrolled

Locally Advanced Rectal Cancer

NCT04174339 2019-11-22

PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer

20 enrolled

Advanced Gastric Adenocarcinoma

NCT03393416 2019-08-29

A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor

Phase 1 Unknown

28 enrolled

Advanced Gastric Cancer

NCT04014101 2019-07-11

SHR-1210

40 enrolled

Carcinoma, Hepatocellular

NCT04004234 2019-07-09

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Phase 1/2 Unknown

20 enrolled

Biliary Tract Neoplasms, Neoplasm Metastasis

NCT03914352 2019-04-16

A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection

40 enrolled

Carcinoma, Hepatocellular, Recurrence

NCT03857815 2019-03-19

Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Hepatocellular Carcinoma

30 enrolled

Carcinoma, Hepatocellular

NCT03671265 2019-01-09

Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

20 enrolled

Esophageal Neoplasms

NCT03722875 2018-12-19

SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery

45 enrolled

Carcinoma, Hepatocellular

NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma